We thus propose that ANGPTL2 can serve as a possible biomarker for detecting SSc-like pathologies at an early stage before the manifestation of dermal thickening and accumulation of ECM, which are gross indications of fibrosis. The gene discussed is ANGPTL2; the disease is systemic sclerosis.